Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes?the EURODIAB Prospective Complications Study
- 4 February 2005
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 48 (2) , 370-378
- https://doi.org/10.1007/s00125-004-1628-8
Abstract
The pathogenesis of vascular complications in type 1 diabetes is poorly understood, but may involve chronic, low-grade inflammation. We investigated the association of markers of inflammation with vascular complications in type 1 diabetes.Keywords
This publication has 42 references indexed in Scilit:
- Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetesKidney International, 2003
- Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppressionThe FASEB Journal, 2002
- Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic thresholdKidney International, 2001
- Markers of Insulin Resistance Are Strong Risk Factors for Retinopathy Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications StudyDiabetes Care, 2001
- Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic diseaseFrontiers in Bioscience-Landmark, 2001
- Diabetic dyslipidemiaThe American Journal of Cardiology, 1998
- Occurrence and interrelationships of complications in insulin-dependent diabetes in FinlandActa Diabetologica, 1997
- Role of growth factors in mesangial cell ion channel regulationKidney International, 1995
- Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.Journal of Clinical Investigation, 1995
- Relationship Between Glycemic Control and Collagen-Linked Advanced Glycosylation End Products in Type I DiabetesDiabetes Care, 1993